Tuesday, 7 August 2012

Food And Drug Administration-Colorectal Cancer-Healthday News

Zaltrap Approved for Advanced Colorectal Cancer

FRIDAY, Aug. 3 (Healthday News) -- Zaltrap (ziv-afilbercept) has been approved by the U.S. Food and Drug Administration in combination with a FOLFIRI chemotherapy regimen for adults with advanced metastatic (spreading) colorectal cancer, the agency said Friday. read more..

No comments:

Post a Comment